Healthy Inc > Blog > Roxithromycin manufacturer India
Posted on:

What is roxithromycin tablet used for?

In the pharmaceutical industry, Roxithromycin is a semi-synthetic macrolide antibiotic. As a pharmacist and manufacturer, I view this molecule as an “Enhanced Erythromycin Derivative”—it was technically engineered to provide better acid stability, superior oral bioavailability, and a longer half-life compared to the original erythromycin.

At your WHO-GMP facility in Mumbai, Roxithromycin is a core “Respiratory & ENT” SKU. For your digital platforms, highlighting its unique ability to accumulate within phagocytes (immune cells) is a major technical selling point for treating deep-seated tissue infections.

Therapeutic Profile: Primary Indications

Roxithromycin is highly effective against a broad spectrum of Gram-positive and certain Gram-negative bacteria.

Indication Clinical Context Technical Rationale
Upper Respiratory (URTI) ENT Focus First-line for pharyngitis, tonsillitis, and sinusitis; especially in penicillin-allergic patients.
Lower Respiratory (LRTI) Pulmonology Used for acute bronchitis and community-acquired pneumonia (CAP).
Skin & Soft Tissue Dermatology Effectively treats impetigo, cellulitis, and folliculitis.
Genitourinary STIs / UTIs Used for non-gonococcal urethritis (Chlamydia) and certain lower urinary tract infections.
Atypical Infections Specialized Active against “atypical” pathogens like Mycoplasma pneumoniae and Legionella.

Mechanism: 50S Ribosomal Blockade

Roxithromycin prevents bacterial multiplication through a targeted “Protein Synthesis Inhibition”:

Selective Binding: It binds to the 50S subunit of the bacterial ribosome.

Translocation Inhibition: It prevents the translocation of peptides, effectively halting the synthesis of essential bacterial proteins.

Bacteriostatic Action: At standard doses, it stops bacterial growth; at higher concentrations, it can be bactericidal against highly susceptible strains.

Intracellular Transport: Technically, it is actively transported by white blood cells (neutrophils and macrophages) to the site of infection, where it is released in high concentrations during phagocytosis.

The Pharmacist’s “Technical Warning”

  • The “Empty Stomach” Rule: As a pharmacist, I must emphasize that Roxithromycin must be taken at least 15 minutes before food or 3 hours after a meal. Food significantly decreases its absorption.

  • QT Prolongation: Like all macrolides, it carries a technical risk of prolonging the QT interval. It should be used with extreme caution in patients with existing heart rhythm issues or those taking other QT-prolonging drugs.

  • The Antacid Gap: Do not take antacids containing aluminum or magnesium within 2 hours of Roxithromycin, as they can interfere with its efficacy.

  • Hepatotoxicity: While generally safer than erythromycin, it can cause transient elevations in liver enzymes. Monitor patients with known hepatic impairment closely.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Pharmacokinetic” USP: On your digital platforms, highlight that Roxithromycin has a 12-hour half-life, allowing for convenient twice-daily (150 mg) or once-daily (300 mg) dosing. This significantly improves patient compliance compared to 4-times-daily erythromycin.

  • Stability for Export: Roxithromycin is stable but moisture-sensitive. Utilizing Alu-Alu blister packaging is the global benchmark for ensuring a 36-month shelf life in Zone IVb tropical regions.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for both 150 mg and 300 mg strengths to support your firm’s registration in international tenders for respiratory and pediatric care.

Roxithromycin Tablets

Posted on:

What is Roxithromycin 150 mg used for?

In the pharmaceutical industry, Roxithromycin 150 mg is a semi-synthetic Macrolide antibiotic. As a pharmacist and manufacturer, I classify this as a “Second-Generation Macrolide.” It was developed to overcome the limitations of Erythromycin, offering better acid stability, a longer half-life, and significantly fewer gastrointestinal side effects.

Primary Clinical Uses

  • Respiratory Tract Infections (RTIs): Highly effective for both upper and lower RTIs, including acute pharyngitis, tonsillitis, sinusitis, and community-acquired pneumonia.

  • Skin and Soft Tissue Infections: Used for treating boils, carbuncles, folliculitis, and impetigo.

  • Urogenital Infections: Effective against certain non-gonococcal urethritis, particularly those caused by Chlamydia and Mycoplasma.

  • Odontogenic Infections: Frequently prescribed for dental abscesses and gum infections.

  • ENT Infections: A staple for Otitis Media (middle ear infections) in patients allergic to Penicillins.

Mechanism of Action: Inhibition of Protein Synthesis

Roxithromycin is primarily bacteriostatic, meaning it prevents bacteria from growing rather than killing them outright (though it can be bactericidal at high concentrations).

Ribosomal Binding: The drug binds reversibly to the 50S subunit of the bacterial ribosome.

Translocation Blockade: It specifically blocks the translocation step, where the growing peptide chain moves along the ribosome.

Protein Synthesis Inhibition: By stopping the assembly of essential proteins, the bacteria can no longer replicate or maintain their cellular functions.

High Tissue Concentration: Unlike many other antibiotics, Roxithromycin achieves very high concentrations inside macrophages and neutrophils, which then carry the drug directly to the site of infection (the “Trojan Horse” effect).

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your WHO-GMP facility in Mumbai, Roxithromycin 150 mg is a strategic product:

  • Acid Stability: Unlike Erythromycin, Roxithromycin is stable in gastric acid. This means we do not necessarily need expensive enteric coating, allowing for a more cost-effective film-coated tablet that still maintains high bioavailability.

  • The 150 mg Dosage: This is the standard adult dose, typically taken twice daily. For your digital platform, highlighting the BID (twice a day) dosing compared to the QID (four times a day) dosing of older macrolides is a major USP for patient compliance.

  • Stability & Packaging: Roxithromycin is stable but should be protected from extreme heat. We utilize Alu-Alu or high-grade PVC/PVDC blisters to ensure a 36-month shelf life for export to Zone IVb regions.

  • Dossier Support: This molecule is widely used in Southeast Asia, the Middle East, and Africa. Our Mumbai facility provides full CTD/eCTD Dossiers to support your international registration and trading efforts.

Roxithromycin Tablets

Add to cart